---
title: "HIK.UK (HIK.UK) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/HIK.UK/news.md"
symbol: "HIK.UK"
name: "HIK.UK"
parent: "https://longbridge.com/en/quote/HIK.UK.md"
datetime: "2026-06-14T04:54:37.974Z"
locales:
  - [en](https://longbridge.com/en/quote/HIK.UK/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/HIK.UK/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/HIK.UK/news.md)
---

# HIK.UK (HIK.UK) — Related News

### [REG - Hikma Pharmaceutical - Holding(s) in Company](https://longbridge.com/en/news/289564831.md)
*2026-06-12T08:00:00.000Z*
> Hikma Pharmaceuticals announced that Wellington Management Group LLP crossed the 5% voting rights threshold on June 9, 2

### [Hikma comments on Supreme Court of the United States' unanimous decision in favour of Hikma | HIK Stock News](https://longbridge.com/en/news/288777072.md)
*2026-06-04T13:40:51.000Z*
> Hikma comments on Supreme Court of the United States' unanimous decision in favour of Hikma | HIK Stock News

### [The U.S. Supreme Court supports generic drug skinny labels, Amarin's patent lawsuit suffers a major setback](https://longbridge.com/en/news/288765045.md)
*2026-06-04T19:50:42.000Z*
> The U.S. Supreme Court unanimously ruled 9 to 0 in favor of generic drug manufacturer Hikma Pharmaceuticals in the "skin

### [Update: Supreme Court Rules Against Amarin in 'Skinny Label' Patent Case](https://longbridge.com/en/news/288756829.md)
*2026-06-04T17:25:00.000Z*
> The US Supreme Court ruled against Amarin (AMRN) in a patent dispute regarding its drug Vascepa. The Court determined th

### [](https://longbridge.com/en/news/288735987.md)
*2026-06-04T14:09:37.000Z*
> Hikma Pharmaceuticals' stock price reached an intraday high, as the U.S. Supreme Court ruled in favor of the company in